Epichaperome inhibition targets kinase and TP53 mutant therapy resistant AML Meeting Abstract


Authors: Carter, B. Z.; Mak, P. Y.; Tao, W.; Ostermann, L. B.; Nishida, Y.; Pemmaraju, N.; Boettcher, S.; Shpall, E. J.; Chiosis, G.; Karras, G.; Wallner, B.; Morgan, R. A.; Andreeff, M.
Abstract Title: Epichaperome inhibition targets kinase and TP53 mutant therapy resistant AML
Meeting Title: 64th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 140
Meeting Dates: 2022 Dec 10-13
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2022-11-15
Start Page: 5930
End Page: 5931
Language: English
ACCESSION: WOS:000893223205459
DOI: 10.1182/blood-2022-158547
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gabriela Chiosis
    279 Chiosis